Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3533 |
|
| Actual shortage: | 232 (7%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3287 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-SALBUTAMOL HFA | 100MCG | METERED-DOSE AEROSOL | Resolved | 2023-07-13 | 2024-05-31 | 198539 |
| APO-SALBUTAMOL HFA | 100MCG | METERED-DOSE AEROSOL | Resolved | 2025-01-10 | 2025-04-04 | 247455 |
| APO-SALBUTAMOL HFA | 100MCG | METERED-DOSE AEROSOL | Anticipated shortage | 2025-07-31 | 2025-07-31 | 263932 |
| APO-SALVENT 5MG/ML | 5MG | SOLUTION | Actual shortage | 2017-08-13 | 2017-10-05 | 19000 |
| APO-SALVENT AEM 100MCG | 100MCG | METERED-DOSE AEROSOL | Actual shortage | 2017-08-13 | 2017-10-05 | 18988 |
| APO-SALVENT STERULES | 1MG | SOLUTION | Actual shortage | 2017-08-13 | 2017-10-05 | 19057 |
| APO-SALVENT STERULES | 2MG | SOLUTION | Actual shortage | 2017-08-13 | 2017-10-05 | 19063 |
| APO-SALVENT STERULES | 0.5MG | SOLUTION | Actual shortage | 2017-08-14 | 2017-10-05 | 19114 |
| APO-SALVENT TABLETS - 4MG | 4MG | TABLET | Resolved | 2017-03-12 | 2017-05-10 | 689 |
| APO-SALVENT-IPRAVENT STERULES | 0.5MG 2.5MG | SOLUTION | Actual shortage | 2017-08-14 | 2017-10-05 | 19323 |
| APO-SAXAGLIPTIN | 5MG | TABLET | Resolved | 2021-12-10 | 2022-01-31 | 150896 |
| APO-SAXAGLIPTIN | 2.5MG | TABLET | Resolved | 2022-01-14 | 2022-07-19 | 152773 |
| APO-SAXAGLIPTIN | 5MG | TABLET | Resolved | 2022-02-04 | 2022-07-11 | 154208 |
| APO-SAXAGLIPTIN | 5MG | TABLET | Resolved | 2024-10-24 | 2025-01-03 | 241063 |
| APO-SAXAGLIPTIN | 5MG | TABLET | Actual shortage | 2025-11-20 | 2025-11-27 | 272344 |
| APO-SERTRALINE | 100MG | CAPSULE | Resolved | 2017-03-17 | 2017-05-01 | 3186 |
| APO-SERTRALINE | 50MG | CAPSULE | Resolved | 2017-05-24 | 2017-10-04 | 11090 |
| APO-SERTRALINE | 25MG | CAPSULE | Resolved | 2017-06-13 | 2017-10-12 | 12698 |
| APO-SERTRALINE | 50MG | CAPSULE | Resolved | 2017-06-19 | 2017-10-04 | 13334 |
| APO-SERTRALINE | 100MG | CAPSULE | Resolved | 2017-06-28 | 2017-10-04 | 14233 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |